Pharmaceutical.
In pharmaceutical applications, every material has a regulatory weight. Specifications, documentation and traceability are not just expected, they define whether a material can be used at all. QMEA supports customers in pharma with intermediates, solvents and reagents used across API development and production, supplied with the level of control and documentation that regulated environments demand.
Our portfolio combines standard commodities and (semi-)specialty materials with tailored solutions, so customers can rely on us for both routine pharmaceutical supply and projects that call for something specific.
Get in touch
Quality and compliance at every step.
In pharmaceutical environments, materials must meet clearly defined specifications and be supported by complete and accurate documentation. QMEA ensures that handling, documentation and supply are aligned with regulatory and quality requirements throughout the process.
We work in line with:
- GMP requirements
- FDA guidelines
- Defined material specifications
- Documentation and traceability standards
By working with qualified partners and controlled processes, we ensure consistency, traceability and compliance across every stage.
Reliable supply in regulated environments.
Reliability in pharmaceutical supply chains goes beyond availability. Materials must be handled, documented and delivered in line with strict regulatory frameworks, where deviations can impact both production and compliance.
QMEA ensures controlled and reliable supply through a network of qualified partners. By aligning specifications, documentation and logistics, we maintain consistency across batches and continuity in supply, even when conditions change.
Product groups for pharmaceutical applications.
QMEA supplies a range of product groups used in pharmaceutical processes, including API development and production. Our portfolio combines standard commodities and (semi-)specialty materials, with tailored solutions developed when specific requirements call for it. Materials are selected based on technical requirements, quality standards and regulatory expectations.
- Pharmaceutical solvents with controlled purity and low residue profiles
- Intermediates for API synthesis
- Reagents for laboratory and production use
- Buffers and buffer components for formulation and analytical processes
- Process aids for controlled and regulated environments
Depending on the application and regulatory requirements, we also support additional components to match specific process and compliance needs.
From standard portfolio to custom solutions.
Most pharmaceutical projects build on materials that are already part of an established portfolio. Others require something more specific, whether driven by a new synthesis route, a tighter spec or a regulatory framework that does not allow compromise.
QMEA covers both. Our portfolio of commodities and (semi-)specialty materials supports the day-to-day needs of pharmaceutical production, while our co-maker approach allows us to develop tailored solutions where standard materials fall short.
When customers face a new requirement or look beyond what is currently available, we extend our reach through our network and capabilities to find or build what fits, always within the same regulatory and quality framework.
Everything you need to know.
We supply key intermediates, solvents and reagents used in pharmaceutical processes, including applications related to API production. Our portfolio covers both standard commodities and (semi-)specialty materials, alongside tailored solutions for specific requirements.
We work with qualified partners and ensure materials and processes align with relevant regulatory frameworks, including GMP and FDA requirements, supported by proper documentation and traceability.
Yes. We supply standard commodities and (semi-)specialty materials from our portfolio, and develop tailored solutions when projects call for something more specific.
We maintain control over the supply chain through qualified partners and structured processes, ensuring consistency across batches and reliable delivery in regulated environments.
Yes. When standard materials no longer meet requirements or availability changes, we support customers in identifying qualified alternatives, always within the applicable regulatory and quality framework.
Yes. We support documentation requirements and ensure that materials are supplied with the necessary information to meet regulatory expectations.
Yes. Samples can be provided to support testing, validation and evaluation within pharmaceutical processes.
Request a sample.
Looking for a reliable supply of pharmaceutical materials or exploring alternatives within a regulated environment? QMEA supports customers across pharma with standard portfolio materials, tailored solutions and the documentation that regulated environments require.
Request a sample or share your specifications, and our team will respond to support your process.
5211 AV 's-Hertogenbosch
The Netherlands
